New oral peptide therapy aims to protect kidneys in chronic disease
NCT ID NCT07187713
First seen Nov 01, 2025 · Last updated Jun 16, 2026 · Updated 37 times
Summary
This study tests a liquid medication called ACE Reno, taken under the tongue four times a day for 12 weeks, in 300 adults with kidney damage from diabetes, high blood pressure, autoimmune diseases, or other causes. The goal is to see if it can reduce protein in the urine and help keep kidney function stable. Participants must already be on standard treatments like blood pressure or diabetes medications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE (STAGE 3-4) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
British Centre For Regenerative medicine BCRMED Global
RECRUITINGGiza, GZ, 12311, Egypt
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.
Conditions inferred from the trial description
These were inferred from the trial's summary, not listed by the trial registrant.